Taiyo Gold Agri Biotech India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 27-12-2024
- Paid Up Capital ₹ 1.00 M
as on 27-12-2024
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.11 Cr
as on 27-12-2024
- Revenue 27.78%
(FY 2022)
- Profit 53.51%
(FY 2022)
- Ebitda 63.10%
(FY 2022)
- Net Worth 32.46%
(FY 2022)
- Total Assets 17.22%
(FY 2022)
About Taiyo Gold Agri Biotech India
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.11 Cr.
Kacham Srinivas and Kacham Ramadevi serve as directors at the Company.
- CIN/LLPIN
U01500TG2010PTC066831
- Company No.
066831
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jan 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Taiyo Gold Agri Biotech India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kacham Srinivas  | Managing Director | 29-Jan-2010 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kacham Ramadevi | Director | 29-Jan-2010 | Current |
Financial Performance of Taiyo Gold Agri Biotech India.
Taiyo Gold Agri Biotech India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 27.78% increase. The company also saw a substantial improvement in profitability, with a 53.51% increase in profit. The company's net worth Soared by an impressive increase of 32.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Taiyo Gold Agri Biotech India?
In 2021, Taiyo Gold Agri Biotech India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 04 Nov 2022 | ₹3.20 M | Open |
Hdfc Bank Limited Creation Date: 08 Aug 2022 | ₹0.44 M | Open |
Others Creation Date: 10 Apr 2015 | ₹2.75 Cr | Open |
How Many Employees Work at Taiyo Gold Agri Biotech India?
Unlock and access historical data on people associated with Taiyo Gold Agri Biotech India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Taiyo Gold Agri Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Taiyo Gold Agri Biotech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
